MOgene
Private Company
Funding information not available
Overview
MOgene is a long-established, private genomic services provider (CRO) catering to biopharma, agriculture, and diagnostic clients. It operates a fee-for-service business model, offering end-to-end project support from experimental design and sequencing (utilizing Illumina and other platforms) to bioinformatics analysis. With a management team featuring notable industry veterans and over 150 peer-reviewed citations, the company has built a reputation for quality and consultative expertise in translating genomic data into actionable insights for research and development.
Technology Platform
Utilizes industry-standard genomic platforms including Illumina short-read NGS, with mentions of PacBio and Agilent, to provide end-to-end sequencing and bioinformatics services.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
MOgene competes with large, global contract research organizations (CROs), sequencing service providers like GENEWIZ (part of Azenta) and Psomagen, and numerous university core facilities. Its differentiation lies in its specialized consultative approach, dual-sector focus (pharma/ag), and long-standing track record in a specific geographic hub.